1.
JCO Precis Oncol
; 8: e2300686, 2024 Jun.
Article
in English
| MEDLINE
| ID: mdl-38905574
ABSTRACT
Case report of a HER2-expressed ovarian clear cell carcinoma with exceptional response to trastuzumab deruxtecan.